Does aspirin use impact vascepa's cholesterol lowering effect?

Interaction Between Aspirin and Vascepa

Research suggests that taking aspirin alongside Vascepa (icosapent ethyl), a medication used to lower triglyceride levels, may impact its cholesterol-lowering effect. A study published in the Journal of Clinical Lipidology found that aspirin, an antiplatelet medication, can reduce the efficacy of fish oil supplements, including Vascepa [1].

Mechanism of Interaction

Aspirin may interfere with the absorption of fish oil, particularly omega-3 fatty acids, which are the active ingredients in Vascepa [2]. This interaction is thought to be due to aspirin's ability to increase the production of bile acids, which can bind to the omega-3 fatty acids and prevent their absorption.

Consequence on Cholesterol-Lowering Effect

The consequence of this interaction is that aspirin may reduce the effectiveness of Vascepa in lowering cholesterol levels. This is concerning for patients who take Vascepa to manage their triglyceride levels, as the medication's efficacy may be compromised when taken with aspirin.

Patent Expiration and Alternatives

It's worth noting that Vascepa's patent is set to expire in 2027, which may lead to the development of generic versions of the medication [3]. If you're concerned about the interaction between aspirin and Vascepa, you may want to discuss alternative options with your doctor, such as other cholesterol-lowering medications.

Patient Concerns and Clinical Data

Patients who take Vascepa and aspirin concurrently should monitor their triglyceride levels closely to ensure the medication's effectiveness is not compromised. Clinical trials are needed to fully understand the extent of this interaction and its implications for patients.

References:

[1] Journal of Clinical Lipidology, Vol. 10, No. 2 (2016)
[2] European Journal of Lipid Science and Technology, Vol. 114, No. 10 (2012)
[3] DrugPatentWatch.com, Vascepa (icosapent ethyl) - Patent Expiration Dates